Showing results (121-130 of 147) with videos related to
Sort By:
Pageof 15
F1000Research|October 6, 2023
Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patientsHannah Gagg, Sophie T Williams, Samantha Conroy, et al.Expert Reviews in Molecular Medicine|October 3, 2022
Precision oncology using ex vivo technology: a step towards individualised cancer care?Sophie T Williams, Greg Wells, Samantha Conroy, et al.Fertility and Sterility|December 1, 1995
Exaggerated effects of progestogen on uterine artery pulsatility index in Turner's syndrome patients receiving hormone replacement therapyM M Biljan, C T Taylor, R Matijevic, et al.European Journal of Applied Physiology|July 25, 2025
The effects of training and sex on cardiac adaptation in elite rowers across a competitive seasonSarah R Henley-Martin, Carly J Brade, Hugh Riddell, et al.Oncotarget|July 30, 2014
FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agentsAbhijit A Patil, Parag Sayal, Marie-Lise Depondt, et al.Communications Biology|October 22, 2024
Loss of CLN3 in microglia leads to impaired lipid metabolism and myelin turnoverSeda Yasa, Elisabeth S Butz, Alessio Colombo, et al.Cancers|March 6, 2021
Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in GlioblastomaNatasha Carmell, Ola Rominiyi, Katie N Myers, et al.Annals of Surgery|December 18, 2024
Patient-reported outcomes of Children with an Anorectal MalformationRichard J Wood, Shruthi Srinivas, Misel Trajanovska, et al.Cell Reports|August 30, 2016
MRNIP/C5orf45 Interacts with the MRN Complex and Contributes to the DNA Damage ResponseChristopher J Staples, Giancarlo Barone, Katie N Myers, et al.Oncotarget|July 24, 2018
The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic responseGiancarlo Barone, Arvind Arora, Anil Ganesh, et al.Pageof 15